The activation of the GPR68-ATF4 signaling pathway can promote the production of the pro-inflammatory factors IL-6 and TNF-α and helps glioblastoma cells to evade immune surveillance, thus enhancing the growth and survival of glioblastoma cells (Kumari et al., 2021; Li et al., 2024). Here, TNF is linked to glioblastoma.